These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15599912)

  • 21. Inhibition of carbonic anhydrase II by thioxolone: a mechanistic and structural study.
    Barrese AA; Genis C; Fisher SZ; Orwenyo JN; Kumara MT; Dutta SK; Phillips E; Kiddle JJ; Tu C; Silverman DN; Govindasamy L; Agbandje-McKenna M; McKenna R; Tripp BC
    Biochemistry; 2008 Mar; 47(10):3174-84. PubMed ID: 18266323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. QSAR studies on benzene sulfonamide carbonic anhydrase inhibitors: need of hydrophobic parameter for topological modeling of binding constants of sulfonamides to human CA-II.
    Khadikar PV; Sharma V; Karmarkar S; Supuran CT
    Bioorg Med Chem Lett; 2005 Feb; 15(4):923-30. PubMed ID: 15686888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thermodynamic optimisation in drug discovery: a case study using carbonic anhydrase inhibitors.
    Scott AD; Phillips C; Alex A; Flocco M; Bent A; Randall A; O'Brien R; Damian L; Jones LH
    ChemMedChem; 2009 Dec; 4(12):1985-9. PubMed ID: 19882701
    [No Abstract]   [Full Text] [Related]  

  • 24. 3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors.
    Sethi KK; Verma SM; Prasanthi N; Sahoo SK; Parhi RN; Suresh P
    Bioorg Med Chem Lett; 2010 May; 20(10):3089-93. PubMed ID: 20443227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.
    Winum JY; Thiry A; Cheikh KE; Dogné JM; Montero JL; Vullo D; Scozzafava A; Masereel B; Supuran CT
    Bioorg Med Chem Lett; 2007 May; 17(10):2685-91. PubMed ID: 17376683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II.
    Bayram E; Senturk M; Kufrevioglu OI; Supuran CT
    Bioorg Med Chem; 2008 Oct; 16(20):9101-5. PubMed ID: 18819808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides.
    Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2007 Apr; 50(7):1651-7. PubMed ID: 17343373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein surface-assisted enhancement in the binding affinity of an inhibitor for recombinant human carbonic anhydrase-II.
    Banerjee AL; Swanson M; Roy BC; Jia X; Haldar MK; Mallik S; Srivastava DK
    J Am Chem Soc; 2004 Sep; 126(35):10875-83. PubMed ID: 15339172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examination of two independent kinetic assays for determining the inhibition of carbonic anhydrases I and II: structure-activity comparison of sulfamates and sulfamides.
    Shank RP; McComsey DF; Smith-Swintosky VL; Maryanoff BE
    Chem Biol Drug Des; 2006 Aug; 68(2):113-9. PubMed ID: 16999776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of new 5-amino-1,3,4-thiadiazole-2-sulfonamide derivatives on human carbonic anhydrase isozymes.
    Kasimoğullari R; Bülbül M; Günhan H; Güleryüz H
    Bioorg Med Chem; 2009 May; 17(9):3295-301. PubMed ID: 19362844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3170-3. PubMed ID: 19435663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudodynamic combinatorial libraries: a receptor-assisted approach for drug discovery.
    Corbett AD; Cheeseman JD; Kazlauskas RJ; Gleason JL
    Angew Chem Int Ed Engl; 2004 Apr; 43(18):2432-6. PubMed ID: 15114583
    [No Abstract]   [Full Text] [Related]  

  • 33. Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
    Mincione F; Starnotti M; Masini E; Bacciottini L; Scrivanti C; Casini A; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3821-7. PubMed ID: 16039853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
    Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
    Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent isothiocyanate inhibitors of carbonic anhydrase: synthesis and evaluation.
    Khobzaoui M; Tillekeratne LM; Hudson RA
    Biochem Biophys Res Commun; 2004 May; 318(1):1-3. PubMed ID: 15110744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbonic anhydrase inhibitors. Inhibition of the cytosolic human isozymes I and II, and the transmembrane, tumor-associated isozymes IX and XII with substituted aromatic sulfonamides activatable in hypoxic tumors.
    Saczewski F; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4846-51. PubMed ID: 16809036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurements.
    Klinger AL; McComsey DF; Smith-Swintosky V; Shank RP; Maryanoff BE
    J Med Chem; 2006 Jun; 49(12):3496-500. PubMed ID: 16759092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Parkkila S; Hilvo M; Supuran CT
    Bioorg Med Chem; 2008 Oct; 16(20):9113-20. PubMed ID: 18819811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.
    De Simone G; Di Fiore A; Menchise V; Pedone C; Antel J; Casini A; Scozzafava A; Wurl M; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2315-20. PubMed ID: 15837316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors.
    Di Fiore A; Pedone C; Antel J; Waldeck H; Witte A; Wurl M; Scozzafava A; Supuran CT; De Simone G
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2669-74. PubMed ID: 18359629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.